SXS SPECTRIS, lovely technical set up, see chart below. https://pbs.twimg.com/media/B1rboOdCcAAeiIq.jpg"
25 Apr '14
IMS today IMHV
10 Jan '14
Trading Update notification
Spectris plc 2013 Trading Update notification - 17 January 2014 10 January 2014 - Spectris plc (SXS: LSE), the productivity-enhancing instrumentation and controls company, will announce its 2013 full year trading update on Friday 17 January 2014 at 07:00 BST. John O'Higgins, Chief Executive and Clive Watson, Group Finance Director, will host an investor and analyst conference call at 08:00 GMT.
22 Feb '13
"The difficult market conditions in the second half of 2012 provided a backdrop for Spectris to demonstrate the quality and resilience of its business model," Michael Blogg, an analyst at Investec, commented this morning. "We have revised our estimates from a basis of ultra-caution to a level achievable in a low-growth environment, with upside potential if markets recover more quickly. The increase in our target price, driven by the 6-7% increase in our earnings per share (EPS) estimates, is not quite enough to justify a more positive recommendation than hold." He added: "Spectris has the spread and market presence to deliver growth in most circumstances, augmented by its organic and bolt-on investments financed out of cash flows and overseen by a highly-respected management team. "It is now within striking distance of the FTSE 100, where we believe it would not look out of place in terms of investment quality.
22 Feb '13
Spectris: N+1 Singer takes target price from 2135p to 2415p, while reiterating a hold recommendation.
20 Feb '13
"The board is confident that Spectris continues to be strategically well-positioned for 2013 and beyond." The group said it expects to see growth in its Life Sciences sector continue, but said its Mining sector looks set to continue to slow in the first half of 2013. "We also see potential in the emerging nano-materials sector, creating demand from academic research institutions, as well as in-house research and development laboratories in the pharmaceutical and advanced materials sectors," it said. Sales in Test & Measurement rose 3.0% on a like-for-like basis, while operating profit grew 0.7%, helped by strong demand from the electronics and telecoms markets and continued growth in automotive. In-line Instrumentation sales climbed 4.0%, and operating profit rose 0.5%, after it experienced good demand from Asia Pacific, Japan and China in particular.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.